Period of time: 2013年5期
Publisher: Future Medicine
Founded in: 2009
Total resources: 6
ISSN: 1750-1911
Subject: R8 Special Medical
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Epigenomics,volume 5,issue 5
Menu
By Laufer Benjamin I,Diehl Eric J,Singh Shiva M in (2013)
Epigenomics,volume 5,issue 5 , Vol. 5, Iss. 5, 2013-10 , pp.By Gurung Buddha,Hua Xianxin in (2013)
Epigenomics,volume 5,issue 5 , Vol. 5, Iss. 5, 2013-10 , pp.Biomarker or pathophysiology? The role of DNA methylation in postpartum depression
By Kimmel Mary,Kaminsky Zachary,Payne Jennifer L in (2013)
Epigenomics,volume 5,issue 5 , Vol. 5, Iss. 5, 2013-10 , pp.News & Views in ... Epigenomics
Epigenomics,volume 5,issue 5 , Vol. 5, Iss. 5, 2013-10 , pp.Research Highlights: PRC2 dysfunction through multiple mechanisms in myeloid malignancies
Epigenomics,volume 5,issue 5 , Vol. 5, Iss. 5, 2013-10 , pp.Interview: Fighting disease from the chromosome end
Epigenomics,volume 5,issue 5 , Vol. 5, Iss. 5, 2013-10 , pp.By Faulk Christopher,Barks Amanda,Liu Kevin,Goodrich Jaclyn M,Dolinoy Dana C in (2013)
Epigenomics,volume 5,issue 5 , Vol. 5, Iss. 5, 2013-10 , pp.By Farooq Muhammad,Wadaan Mohammad AM in (2013)
Epigenomics,volume 5,issue 5 , Vol. 5, Iss. 5, 2013-10 , pp.Establishing the clinical utility of epigenetic markers in cancer: many challenges ahead
By Zarzour Peter,Hesson Luke B,Ward Robyn L in (2013)
Epigenomics,volume 5,issue 5 , Vol. 5, Iss. 5, 2013-10 , pp.Epigenetic regulation of cell signaling pathways in acute lymphoblastic leukemia
By San Jose-Eneriz Edurne,Agirre Xabier,Rodríguez-Otero Paula,Prosper Felipe in (2013)
Epigenomics,volume 5,issue 5 , Vol. 5, Iss. 5, 2013-10 , pp.